Go Pro

TD Cowen's Rating of Yarrow Bioscience on 7/28/2026

On July 28, 2026, TD Cowen updated its outlook on Yarrow Bioscience (NASDAQ:YARW) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from TD Cowen

DateCompanyAction
7/31/2026
Uniti Group Inc. stock logo
UNIT
Uniti Group
Lower Price Target
7/31/2026
Upbound Group, Inc. stock logo
UPBD
Upbound Group
Lower Price Target
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price Target
7/31/2026
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
Boost Price Target
7/31/2026
O'Reilly Automotive, Inc. stock logo
ORLY
O'Reilly Automotive
Lower Price Target
7/31/2026
Roblox Corporation stock logo
RBLX
Roblox
Lower Price Target
More Ratings From TD Cowen